Latest Announcement

Save the Date: The Annual Rosenman Symposium is on June 22, 2016. 
Meet medical device entrepreneurs and hear from the experts.

Learn More

Incubators at QB3

Find lab space at one of our five incubators close to UC faculty and resources.

CTA

QB3 Ecosystem

Tap into the QB3 network of resources, funding, and core facilities, across three UC campuses.

CTA

Jobs

Your career in the life sciences starts here. Check current job listings at startups in the Bay Area. 

CTA

Impact in Numbers

Partner with us to gain access to the most innovative life science startups, and make your next big strategic investment.

 
$600 million in funding

$600 million in
funding

$161 million in revenue

$161 million in
revenue

411+ early-stage companies

411+ early-stage
companies

275+ companies Startup In a Box

275+ companies
Startup In a Box

Leading innovative pharma partners

Leading innovative
pharma partners

 

*Totam rem aperiam eaque ipsa quae ab illo inventore veritatis.

IN THE NEWS

QB3 in the News
OncoSynergy submits FDA application for clinical trial of therapy for malignant brain cancer
OncoSynergy submits FDA application for clinical trial of therapy for malignant brain cancer

Glioblastoma is the most common primary brain cancer in adults.

Read More →
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs

Last year, Alector advanced two drugs into early-stage clinical testing.

Read More →
Epalex gets backing for migraine, epilepsy treatments
Epalex gets backing for migraine, epilepsy treatments

Epalex is a member of the 2017 Biotech/Biopharma Pitch Summit cohort.

Read More →

10.27.16

Lorem ipsum

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur duis en sied. Dolorem ipsum quia dolor et siet parro voluptatem sit amet. Excepteur sint occaecat sit cupidatat non proident.

CTA

Partners